Experimental evolution to discover mechanisms of multidrug resistance and new treatment strategies to combat the novel ‘superbug’ Candida auris. KU Leuven
Antifungal resistance is emerging on a scale that has never been documented before. Invasive, multidrug-resistant fungal infections are posing an increasing threat to public health, further complicated by the availability of only three major antifungal drug classes. The antifungal resistance crisis is embodied by the novel ‘superbug’ C. auris. After its first identification in 2009, this opportunistic pathogen has emerged worldwide and shown ...